Diabetes-induced vascular dysfunction involves arginase I - Wikidata - awgldk - TriplyDB

Diabetes-induced vascular dysfunction involves arginase I

Diabetes-induced vascular dysfunction involves arginase I

http://www.wikidata.org/entity/Q35906453

about

Targeting Nitric Oxide with Natural Derived Compounds as a Therapeutic Strategy in Vascular Diseases Role for high-glucose-induced protein O-GlcNAcylation in stimulating cardiac fibroblast collagen synthesis Vitamin D is a regulator of endothelial nitric oxide synthase and arterial stiffness in mice Effect of medicinal mushrooms on blood cells under conditions of diabetes mellitus Novel therapeutic strategies for adult obese asthmatics.Rho/Rho-associated coiled-coil forming kinase pathway as therapeutic targets for statins in atherosclerosis.Arginase 2 deficiency prevents oxidative stress and limits hyperoxia-induced retinal vascular degeneration.The role of arginase I in diabetes-induced retinal vascular dysfunction in mouse and rat models of diabetes.New approaches to the design and discovery of therapies to prevent erectile dysfunction.Arginase in retinopathy.Akita spontaneously type 1 diabetic mice exhibit elevated vascular arginase and impaired vascular endothelial and nitrergic function.Requirement of NOX2 expression in both retina and bone marrow for diabetes-induced retinal vascular injury.Role of hydrogen sulfide in skeletal muscle biology and metabolism.Angiotensin II-induced arterial thickening, fibrosis and stiffening involves elevated arginase function Comparison of the effect of topical versus systemic L-arginine on wound healing in acute incisional diabetic rat model.Tissue-specific up-regulation of arginase I and II induced by p38 MAPK mediates endothelial dysfunction in type 1 diabetes mellitus.Deregulation of arginase induces bone complications in high-fat/high-sucrose diet diabetic mouse model Prevention of diabetes-induced arginase activation and vascular dysfunction by Rho kinase (ROCK) knockout.Arginase promotes skeletal muscle arteriolar endothelial dysfunction in diabetic rats Vasomotor regulation of coronary microcirculation by oxidative stress: role of arginase.Insights into the arginine paradox: evidence against the importance of subcellular location of arginase and eNOS.l-Citrulline Protects from Kidney Damage in Type 1 Diabetic Mice.Arginase 2 promotes neurovascular degeneration during ischemia/reperfusion injury.Arginase 2 deficiency reduces hyperoxia-mediated retinal neurodegeneration through the regulation of polyamine metabolism.Arginase as a potential target in the treatment of cardiovascular disease: reversal of arginine steal?RhoA/mDia-1/profilin-1 signaling targets microvascular endothelial dysfunction in diabetic retinopathy.Arginase: an old enzyme with new tricks.Endothelial dysfunction and vascular disease - a 30th anniversary update.Arginase Inhibitors: A Rational Approach Over One Century.Arginase as a mediator of diabetic retinopathy.Effects of the Hydroalcoholic Extract of Zingiber officinale on Arginase I Activity and Expression in the Retina of Streptozotocin-Induced Diabetic Rats.The subcellular compartmentalization of arginine metabolizing enzymes and their role in endothelial dysfunction.Obesity-induced vascular dysfunction and arterial stiffening requires endothelial cell arginase 1.Differential expression of genes identified by suppression subtractive hybridization in liver and adipose tissue of gerbils with diabetes.Mechanisms of Diabetes-Induced Endothelial Cell Senescence: Role of Arginase 1.Deletion of endothelial arginase 1 does not improve vasomotor function in diabetic mice.single nucleotide polymorphisms rs2781666 and rs2781665 confer risk of Type 2 diabetes mellitus

P2860

Q28073279-3655D5B0-2EC5-4E65-93FA-7050658EC0F7 Q33569387-7F17C956-C090-46C8-B24C-23A51574B502 Q33663682-E33E8FB6-EC7A-4487-8897-9010B7AAAEA9 Q33706752-CF3E0163-F508-468A-AFFC-D04F07262593 Q34290008-81D74F43-2E50-4019-B5F7-998FE23A90A1 Q34362144-ABD90202-DE75-431E-8CC7-94D83910B526 Q34465434-8D7B72CA-0FFB-43BC-928E-1035B9CB69B2 Q34509144-B6D5FC69-3287-4F33-A8E2-F61D88AECF04 Q34664336-CC053144-0C9C-40AC-8E5C-D933F15DBE69 Q34800913-34756862-E6AE-4BA9-AC31-3C80964A580D Q34973749-AD557171-8E39-4CF8-A63D-CF8A9A6F1805 Q35073329-A42B342C-A636-4DD8-A61F-349CC28FF87F Q35181112-4A70D07B-7F0E-429C-8AA3-0B5C76C93E97 Q35217395-50228133-D2E2-43FB-A6FF-B508D7309353 Q35744798-33A8B267-048F-44A2-852E-B1A360002878 Q36124220-E9D71F4F-0D8B-46DD-9FF7-C511B472469F Q36775423-E173F605-16B0-4F00-B1B5-24CDEEC42AE6 Q36787307-D4F55EC7-4EE4-417E-AA1F-BA915F308FEB Q36854784-5F225EE1-1060-4B6B-A74F-75D0E40CFBD7 Q37102697-90370625-0CBC-48B5-A92D-2B3DB7CB8533 Q37142734-6D9441E4-8888-4C77-8B9D-EAE2B4C28EB0 Q37412089-666BD0C4-6AC6-47D0-B265-32AE40153129 Q37603245-4604FE4F-06BD-4CA6-A168-C6C65096E176 Q37620647-9ECC6B25-3F42-4BA4-A1DB-0E1EFBF7867E Q38082329-0F1645F1-5A6B-4846-8699-5CC53532E949 Q38384340-8AE39A65-DA57-40AB-B447-91212B899080 Q38452432-30C509BE-495A-4835-BE5E-80E834BF5074 Q38680112-D1CEFE9A-8855-4CFA-B465-3DCBDB980D2F Q39012928-E4D77A18-C350-4053-8F93-428358EE8149 Q41285088-341220AA-F366-4B84-B426-4E7E7745E8AF Q41384119-F63701C4-9FE5-4678-9607-738BD9B4EC57 Q43101543-E340651A-0E4F-4F47-BEFF-52C3E6250C7F Q47734746-52882DAE-EC1A-4DEA-B7FF-7563CEFF2BAA Q48114214-2ACA9D91-C723-46C7-B7BF-08882959E435 Q55153776-F1E28A3B-4226-43AC-935D-572C440D9CB9 Q55242323-E3FDF5BE-CC6E-4F79-979E-098DCEDED864 Q58700252-B1DBEA63-6B46-496A-8633-9D96DC520D67

P2860

Diabetes-induced vascular dysfunction involves arginase I

http://www.wikidata.org/entity/Q35906453

description

2011 nî lūn-bûn

@nan

2011年の論文

@ja

2011年学术文章

@wuu

2011年学术文章

@zh-cn

2011年学术文章

@zh-hans

2011年学术文章

@zh-my

2011年学术文章

@zh-sg

2011年學術文章

@yue

2011年學術文章

@zh

2011年學術文章

@zh-hant

name

Diabetes-induced vascular dysfunction involves arginase I

@ast

Diabetes-induced vascular dysfunction involves arginase I

@en

type

label

Diabetes-induced vascular dysfunction involves arginase I

@ast

Diabetes-induced vascular dysfunction involves arginase I

@en

prefLabel

Diabetes-induced vascular dysfunction involves arginase I

@ast

Diabetes-induced vascular dysfunction involves arginase I

@en

P1433

Q35906453-6E78F13B-4C98-40BD-AA4F-20AC8895DE06

P1476

Q35906453-F9985E89-40A4-43AA-A087-913E1DCF1CAF

P2093

Q35906453-1F26E581-9B82-4F4A-9489-21D0FB9D2CD3

Q35906453-2E235D57-4C86-4548-9D8E-9F19E7FE5B69

Q35906453-484438F5-D006-4C09-AF05-F2ED5F0707AC

Q35906453-8C72A0DB-6381-413D-9DD7-B1EACABE57CB

Q35906453-98FBC899-6069-4982-ACB6-E1B522868645

Q35906453-AC77C5C7-FF00-4A26-88BC-60B0943A1E6F

Q35906453-BE5F100D-5141-41F5-B34E-0EB11A1AA4E9

Q35906453-F156DE15-95A0-4DAA-81CE-99DB2D49C500

P2860

Q35906453-097A7C3A-7237-4A12-8B22-46DDB0722FEC

Q35906453-0E856931-9D29-4F29-B0E4-23EE9E79CFF3

Q35906453-153FCAA7-A576-4B16-8B3D-02DE494CDCC7

Q35906453-16617716-1FA6-40EF-9EB4-55816A494316

Q35906453-16C26E07-D37F-4220-8559-8E827D5012CA

Q35906453-1B344AAB-18B4-4114-825D-502E3849F847

Q35906453-2DE14C15-D9AD-4826-A0FC-A1379BBB617D

Q35906453-34C6BA8C-14F6-449E-BAE8-A5DD334B1087

Q35906453-4F2A4155-49B4-4604-817A-55CE83AC0A96

Q35906453-5ACA2631-AB12-44DE-9700-8E20854859AF

P304

Q35906453-015ADBC4-E93A-4C97-B06F-5923B0FD63A1

P31

Q35906453-C483829D-B3A0-4C84-B4E5-6FC494976F9D

P356

Q35906453-BE938845-0B48-41B5-B891-F1249F2FF3B0

P433

Q35906453-0691BA51-5891-4678-A2CB-E1DC4F4EEEBC

P478

Q35906453-87598E7D-B91A-495C-9832-C7F193CF25DC

P577

Q35906453-1C50ADB0-3F92-472C-87A4-FCABF358FFA0

P698

Q35906453-88EFE93D-AB98-4026-878D-6FB288A88E67

P932

Q35906453-47883920-D63C-4DC1-88AE-D5E8A69C578E

P356

AJPHEART.00774.2011

P1433

American Journal of Physiology - Heart and Circulatory Physiology

P1476

Diabetes-induced vascular dysfunction involves arginase I

@en

P2093

Daniel H Platt

http://www.w3.org/2001/XMLSchema#string

David W Stepp

http://www.w3.org/2001/XMLSchema#string

Jennifer A Iddings

http://www.w3.org/2001/XMLSchema#string

M Irfan Ali

http://www.w3.org/2001/XMLSchema#string

Maritza J Romero

http://www.w3.org/2001/XMLSchema#string

Robert W Caldwell

http://www.w3.org/2001/XMLSchema#string

Ruth B Caldwell

http://www.w3.org/2001/XMLSchema#string

Stephen D Cederbaum

http://www.w3.org/2001/XMLSchema#string

P2860

Mechanisms, Pathophysiology, and Therapy of Arterial Stiffness

Regulatory role of arginase I and II in nitric oxide, polyamine, and proline syntheses in endothelial cells

The pathobiology of diabetic complications: a unifying mechanism

Protein disregulation in red blood cell membranes of type 2 diabetic patients.

Vascular dysfunction in retinopathy-an emerging role for arginase

Endothelial dysfunction in diabetes mellitus: molecular mechanisms and clinical implications.

p38 Mitogen-activated protein kinase (MAPK) increases arginase activity and contributes to endothelial dysfunction in corpora cavernosa from angiotensin-II-treated mice

Vascular oxidative stress: the common link in hypertensive and diabetic vascular disease.

Arginase 1 contributes to diminished coronary arteriolar dilation in patients with diabetes

Angiotensin II-induced vascular endothelial dysfunction through RhoA/Rho kinase/p38 mitogen-activated protein kinase/arginase pathway.

P304

H159-66

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1152/AJPHEART.00774.2011

http://www.w3.org/2001/XMLSchema#string

P433

1

http://www.w3.org/2001/XMLSchema#string

P478

302

http://www.w3.org/2001/XMLSchema#string

P577

2011-11-04T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

22058149

http://www.w3.org/2001/XMLSchema#string

P932

3334242

http://www.w3.org/2001/XMLSchema#string